Nathanael S Gray Selected Research

Nathanael S Gray Research Topics

Disease

136	Neoplasms (Cancer) 10/2022 - 03/2006
20	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2008
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2009
11	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2011
11	Neuroblastoma 01/2021 - 05/2008
11	Leukemia 01/2020 - 02/2009
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 09/2010
7	Parkinson Disease (Parkinson's Disease) 01/2017 - 04/2011
6	Lymphoma (Lymphomas) 01/2022 - 01/2007
6	Inflammation (Inflammations) 01/2020 - 03/2009
6	Infections 01/2019 - 01/2016
6	Melanoma (Melanoma, Malignant) 01/2019 - 12/2009
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 02/2006
4	Multiple Myeloma 01/2022 - 05/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2016
4	Ewing Sarcoma (Sarcoma, Ewing) 10/2021 - 03/2012
4	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2016
4	Disease Progression 01/2020 - 01/2018
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018 - 01/2007
4	Carcinogenesis 01/2018 - 03/2008
4	Adenocarcinoma of Lung 01/2017 - 12/2010
3	Immune System Diseases (Immune Disorders) 12/2021 - 08/2015
3	Adenocarcinoma 01/2021 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2016
3	Dengue (Dengue Fever) 01/2019 - 01/2016
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 10/2018
3	Osteosarcoma (Osteogenic Sarcoma) 02/2016 - 09/2012
3	Aneuploidy (Aneuploid) 09/2013 - 03/2008
2	Tauopathies 01/2022 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2021
2	Cholangiocarcinoma 12/2021 - 01/2018
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2021 - 01/2018
2	Chordoma 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2015

Drug/Important Bio-Agent (IBA)

75	Phosphotransferases (Kinase)IBA 04/2022 - 12/2007
27	Pharmaceutical PreparationsIBA 01/2022 - 12/2007
25	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2006
11	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 07/2012
11	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2013
11	Anaplastic Lymphoma KinaseIBA 10/2018 - 05/2008
10	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2011
10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2009
10	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2011
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 12/2009
9	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 02/2006
8	CrizotinibIBA 12/2015 - 02/2010
7	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 01/2014
7	CytokinesIBA 12/2021 - 05/2009
7	ibrutinibIBA 11/2021 - 10/2015
7	Protein Kinases (Protein Kinase)IBA 10/2020 - 10/2012
7	Leucine (L-Leucine)FDA Link 01/2017 - 04/2011
6	Tyrosine (L-Tyrosine)FDA Link 04/2022 - 03/2010
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 03/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2012
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2018 - 06/2011
6	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 05/2008
6	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2009
5	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2017
5	Sirolimus (Rapamycin)FDA Link 01/2014 - 03/2009
4	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2008
4	LigandsIBA 12/2021 - 08/2015
4	SaltsIBA 01/2021 - 01/2016
4	Doublecortin-Like KinasesIBA 01/2021 - 01/2020
4	Mitogen-Activated Protein Kinase 7IBA 01/2020 - 10/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2010
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021 - 01/2021
3	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021 - 01/2020
3	AntibodiesIBA 01/2019 - 01/2018
3	Biological ProductsIBA 12/2018 - 07/2008
3	Mitogen-Activated Protein KinasesIBA 01/2018 - 12/2009
3	VemurafenibIBA 01/2018 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2014
3	NVP-TAE684IBA 02/2016 - 01/2007
3	ALW-II-41-27IBA 01/2016 - 05/2014
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2016 - 03/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015 - 03/2009
3	AZD 6244IBA 11/2014 - 12/2009
3	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 10/2010
3	TOR Serine-Threonine KinasesIBA 01/2012 - 10/2010
2	src-Family KinasesIBA 01/2022 - 09/2014
2	Immunomodulating AgentsIBA 01/2022 - 01/2021
2	tau Proteins (tau Protein)IBA 01/2022 - 01/2019
2	Janus KinasesIBA 12/2021 - 08/2015
2	venetoclaxIBA 11/2021 - 01/2019
2	abemaciclibIBA 11/2021 - 10/2021
2	RNA Polymerase II (RNA Polymerase B)IBA 10/2021 - 01/2021
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 08/2015
2	Cyclin-Dependent Kinase 9IBA 01/2021 - 01/2018
2	YKL-05-099IBA 01/2021 - 01/2020
2	YKL-5-124IBA 01/2021 - 01/2020
2	Gemcitabine FDA Link 01/2021 - 01/2017
2	Brachyury protein (Brachyury)IBA 01/2021 - 01/2019
2	phosphatidylinositol 5-phosphateIBA 03/2020 - 01/2020
2	LipidsIBA 01/2020 - 07/2012
2	Drug CombinationsIBA 01/2020 - 11/2014
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018

Therapy/Procedure

55	Therapeutics 10/2022 - 10/2008
6	Drug Therapy (Chemotherapy) 01/2021 - 10/2008
4	Immunotherapy 01/2021 - 01/2018
2	Oral Administration 11/2021 - 11/2014